UniProt ID | S27A2_HUMAN | |
---|---|---|
UniProt AC | O14975 | |
Protein Name | Very long-chain acyl-CoA synthetase | |
Gene Name | SLC27A2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 620 | |
Subcellular Localization |
Endoplasmic reticulum membrane Multi-pass membrane protein. Peroxisome membrane Multi-pass membrane protein. Peripheral membrane associated with the lumenal side of peroxisomes. |
|
Protein Description | Acyl-CoA synthetase probably involved in bile acid metabolism. Proposed to activate C27 precursors of bile acids to their CoA thioesters derivatives before side chain cleavage via peroxisomal beta-oxidation occurs. In vitro, activates 3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanate (THCA), the C27 precursor of cholic acid deriving from the de novo synthesis from cholesterol. Does not utilize C24 bile acids as substrates. In vitro, also activates long- and branched-chain fatty acids and may have additional roles in fatty acid metabolism. May be involved in translocation of long-chain fatty acids (LFCA) across membranes (By similarity).. | |
Protein Sequence | MLSAIYTVLAGLLFLPLLVNLCCPYFFQDIGYFLKVAAVGRRVRSYGKRRPARTILRAFLEKARQTPHKPFLLFRDETLTYAQVDRRSNQVARALHDHLGLRQGDCVALLMGNEPAYVWLWLGLVKLGCAMACLNYNIRAKSLLHCFQCCGAKVLLVSPELQAAVEEILPSLKKDDVSIYYVSRTSNTDGIDSFLDKVDEVSTEPIPESWRSEVTFSTPALYIYTSGTTGLPKAAMITHQRIWYGTGLTFVSGLKADDVIYITLPFYHSAALLIGIHGCIVAGATLALRTKFSASQFWDDCRKYNVTVIQYIGELLRYLCNSPQKPNDRDHKVRLALGNGLRGDVWRQFVKRFGDICIYEFYAATEGNIGFMNYARKVGAVGRVNYLQKKIITYDLIKYDVEKDEPVRDENGYCVRVPKGEVGLLVCKITQLTPFNGYAGAKAQTEKKKLRDVFKKGDLYFNSGDLLMVDHENFIYFHDRVGDTFRWKGENVATTEVADTVGLVDFVQEVNVYGVHVPDHEGRIGMASIKMKENHEFDGKKLFQHIADYLPSYARPRFLRIQDTIEITGTFKHRKMTLVEEGFNPAVIKDALYFLDDTAKMYVPMTEDIYNAISAKTLKL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
22 | S-palmitoylation | LPLLVNLCCPYFFQD HHHHHHHHCHHHHHH | 1.53 | 29575903 | |
23 | S-palmitoylation | PLLVNLCCPYFFQDI HHHHHHHCHHHHHHH | 3.27 | 29575903 | |
158 | Phosphorylation | GAKVLLVSPELQAAV CCEEEEECHHHHHHH | 16.78 | - | |
171 | Phosphorylation | AVEEILPSLKKDDVS HHHHHHHHCCCCCEE | 49.75 | 24719451 | |
173 | Ubiquitination | EEILPSLKKDDVSIY HHHHHHCCCCCEEEE | 59.50 | 32015554 | |
174 | 2-Hydroxyisobutyrylation | EILPSLKKDDVSIYY HHHHHCCCCCEEEEE | 65.54 | - | |
174 | Ubiquitination | EILPSLKKDDVSIYY HHHHHCCCCCEEEEE | 65.54 | 33845483 | |
225 | O-linked_Glycosylation | TPALYIYTSGTTGLP CCEEEEEECCCCCCC | 15.89 | 28510447 | |
226 | O-linked_Glycosylation | PALYIYTSGTTGLPK CEEEEEECCCCCCCC | 19.71 | 28510447 | |
238 | Phosphorylation | LPKAAMITHQRIWYG CCCCHHCCCCCEECC | 10.00 | 20068231 | |
244 | Phosphorylation | ITHQRIWYGTGLTFV CCCCCEECCCCCCHH | 11.48 | 20068231 | |
246 | Phosphorylation | HQRIWYGTGLTFVSG CCCEECCCCCCHHCC | 17.20 | 20068231 | |
249 | Phosphorylation | IWYGTGLTFVSGLKA EECCCCCCHHCCCCC | 24.28 | 20068231 | |
252 | Phosphorylation | GTGLTFVSGLKADDV CCCCCHHCCCCCCCE | 33.93 | 20068231 | |
272 | Ubiquitination | PFYHSAALLIGIHGC CCCHHHHHHHHHHHH | 3.42 | 24816145 | |
279 | Ubiquitination | LLIGIHGCIVAGATL HHHHHHHHHHHHHHH | 1.08 | 24816145 | |
291 | Acetylation | ATLALRTKFSASQFW HHHHHHCCCCHHHHH | 30.78 | 25825284 | |
293 | Phosphorylation | LALRTKFSASQFWDD HHHHCCCCHHHHHHH | 28.68 | 28857561 | |
295 | Phosphorylation | LRTKFSASQFWDDCR HHCCCCHHHHHHHHH | 25.39 | 28857561 | |
303 | Ubiquitination | QFWDDCRKYNVTVIQ HHHHHHHHCCCCHHH | 47.73 | - | |
304 | Phosphorylation | FWDDCRKYNVTVIQY HHHHHHHCCCCHHHH | 8.77 | - | |
322 | Phosphorylation | LLRYLCNSPQKPNDR HHHHHHCCCCCCCCC | 27.93 | 20873877 | |
325 | Ubiquitination | YLCNSPQKPNDRDHK HHHCCCCCCCCCCCH | 49.53 | 24816145 | |
332 | Ubiquitination | KPNDRDHKVRLALGN CCCCCCCHHHHHHCC | 33.08 | 24816145 | |
336 | Ubiquitination | RDHKVRLALGNGLRG CCCHHHHHHCCCCCH | 11.67 | 29967540 | |
337 | Ubiquitination | DHKVRLALGNGLRGD CCHHHHHHCCCCCHH | 6.92 | 29967540 | |
345 | Neddylation | GNGLRGDVWRQFVKR CCCCCHHHHHHHHHH | 5.17 | 32015554 | |
345 | Ubiquitination | GNGLRGDVWRQFVKR CCCCCHHHHHHHHHH | 5.17 | 21890473 | |
345 | Ubiquitination | GNGLRGDVWRQFVKR CCCCCHHHHHHHHHH | 5.17 | 22817900 | |
350 | Ubiquitination | GDVWRQFVKRFGDIC HHHHHHHHHHHHCEE | 3.09 | 22817900 | |
366 | Ubiquitination | YEFYAATEGNIGFMN EEEEECCCCCCCCHH | 45.58 | 33845483 | |
389 | Ubiquitination | GRVNYLQKKIITYDL HHHHHHHHHEEEEEE | 43.26 | 32015554 | |
389 | 2-Hydroxyisobutyrylation | GRVNYLQKKIITYDL HHHHHHHHHEEEEEE | 43.26 | - | |
390 | Ubiquitination | RVNYLQKKIITYDLI HHHHHHHHEEEEEEE | 26.78 | 29967540 | |
393 | Phosphorylation | YLQKKIITYDLIKYD HHHHHEEEEEEEECE | 17.92 | - | |
394 | Ubiquitination | LQKKIITYDLIKYDV HHHHEEEEEEEECEE | 9.80 | 23503661 | |
395 | Ubiquitination | QKKIITYDLIKYDVE HHHEEEEEEEECEEC | 33.01 | 23503661 | |
398 | Ubiquitination | IITYDLIKYDVEKDE EEEEEEEECEECCCC | 42.57 | 22817900 | |
398 | Neddylation | IITYDLIKYDVEKDE EEEEEEEECEECCCC | 42.57 | 32015554 | |
403 | 2-Hydroxyisobutyrylation | LIKYDVEKDEPVRDE EEECEECCCCCCCCC | 68.21 | - | |
403 | Ubiquitination | LIKYDVEKDEPVRDE EEECEECCCCCCCCC | 68.21 | 22817900 | |
419 | Ubiquitination | GYCVRVPKGEVGLLV CEEEEECCCCEEEEE | 65.92 | 29901268 | |
442 | Ubiquitination | FNGYAGAKAQTEKKK CCCCCCCCCHHCHHH | 39.86 | 32015554 | |
447 | Ubiquitination | GAKAQTEKKKLRDVF CCCCHHCHHHHHHHH | 59.60 | 23503661 | |
448 | Ubiquitination | AKAQTEKKKLRDVFK CCCHHCHHHHHHHHH | 51.30 | 23503661 | |
487 | Ubiquitination | RVGDTFRWKGENVAT CCCCCEEECCCCCEE | 14.60 | 29967540 | |
522 | Ubiquitination | VHVPDHEGRIGMASI EECCCCCCCEEEEEE | 24.08 | 29967540 | |
528 | Phosphorylation | EGRIGMASIKMKENH CCCEEEEEEEEECCC | 17.53 | - | |
532 | 2-Hydroxyisobutyrylation | GMASIKMKENHEFDG EEEEEEEECCCCCCH | 50.81 | - | |
536 | Ubiquitination | IKMKENHEFDGKKLF EEEECCCCCCHHHHH | 57.95 | 29967540 | |
540 | Ubiquitination | ENHEFDGKKLFQHIA CCCCCCHHHHHHHHH | 48.42 | 29967540 | |
547 | Ubiquitination | KKLFQHIADYLPSYA HHHHHHHHHHCHHHC | 9.40 | 29967540 | |
552 | Phosphorylation | HIADYLPSYARPRFL HHHHHCHHHCCCCEE | 28.91 | 27050516 | |
563 | Ubiquitination | PRFLRIQDTIEITGT CCEEEEEEEEEEEEC | 47.48 | 29967540 | |
564 | Phosphorylation | RFLRIQDTIEITGTF CEEEEEEEEEEEECC | 12.25 | 30301811 | |
568 | Phosphorylation | IQDTIEITGTFKHRK EEEEEEEEECCCCCC | 19.85 | 30301811 | |
570 | Phosphorylation | DTIEITGTFKHRKMT EEEEEEECCCCCCEE | 22.36 | 30301811 | |
575 | Ubiquitination | TGTFKHRKMTLVEEG EECCCCCCEEEHHCC | 35.64 | 29967540 | |
576 | Sulfoxidation | GTFKHRKMTLVEEGF ECCCCCCEEEHHCCC | 3.36 | 21406390 | |
577 | Phosphorylation | TFKHRKMTLVEEGFN CCCCCCEEEHHCCCC | 30.59 | 25159151 | |
589 | Ubiquitination | GFNPAVIKDALYFLD CCCHHHHHHHHHHHC | 30.28 | 29967540 | |
600 | Ubiquitination | YFLDDTAKMYVPMTE HHHCCCCCCCCCCCH | 32.62 | 29967540 | |
602 | Phosphorylation | LDDTAKMYVPMTEDI HCCCCCCCCCCCHHH | 10.74 | - | |
610 | Phosphorylation | VPMTEDIYNAISAKT CCCCHHHHHHHHHHH | 15.74 | - | |
616 | Ubiquitination | IYNAISAKTLKL--- HHHHHHHHHCCC--- | 47.82 | 29967540 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of S27A2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of S27A2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of S27A2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ABCD1_HUMAN | ABCD1 | physical | 16781659 | |
PEX14_HUMAN | PEX14 | physical | 10198260 | |
SDHA_HUMAN | SDHA | physical | 10198260 | |
CALR_HUMAN | CALR | physical | 10198260 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-577, AND MASSSPECTROMETRY. |